Treating central sleep apnea in heart failure: outcomes revisited.
Olson
Lyle J
LJ
Somers
Virend K
VK
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000367:Age Factors; D015415:Biomarkers; D002639:Cheyne-Stokes Respiration / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D015897:Comorbidity; D045422:Continuous Positive Airway Pressure; D006333:Heart Failure / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology / Q000601:surgery; D016027:Heart Transplantation; D006801:Humans; D011312:Pressure; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D020182:Sleep Apnea, Central / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D020181:Sleep Apnea, Obstructive / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D013318:Stroke Volume; D016019:Survival Analysis; D035423:Thoracic Cavity; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D015415:Biomarkers